International Journal of Radiation Oncology * Biology * Physics
Volume 50, Issue 5 , Pages 1123-1135 , 1 August 2001

High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications

Presented at the 86th RSNA Annual Meeting, Chicago, IL, November 27, 2000.

  • Robson Ferrigno, M.D.

      Affiliations

    • Department of Radiation Oncology, Hospital do Câncer A.C. Camargo, São Paulo, Brazil
    • Corresponding Author InformationReprint requests to: Robson Ferrigno, M.D., Hospital do Câncer A.C. Camargo, Departamento de Radioterapia, Rua Prof. Antonio Prudente, 211 Liberdade, São Paulo - SP, Brazil 01509-010. Tel: +55.11.9976-2439; Fax: +.55.11.3272-9613
    • ,
  • Paulo Eduardo Ribeiro dos Santos Novaes, M.D.

      Affiliations

    • Department of Radiation Oncology, Hospital do Câncer A.C. Camargo, São Paulo, Brazil
    • ,
  • Antonio Cássio Assis Pellizzon, M.D.

      Affiliations

    • Department of Radiation Oncology, Hospital do Câncer A.C. Camargo, São Paulo, Brazil
    • ,
  • Maria Aparecida Conte Maia, M.D.

      Affiliations

    • Department of Radiation Oncology, Hospital do Câncer A.C. Camargo, São Paulo, Brazil
    • ,
  • Ricardo César Fogarolli, M.D.

      Affiliations

    • Department of Radiation Oncology, Hospital do Câncer A.C. Camargo, São Paulo, Brazil
    • ,
  • André Cavalcanti Gentil

      Affiliations

    • Department of Radiation Oncology, Hospital do Câncer A.C. Camargo, São Paulo, Brazil
    • ,
  • João Victor Salvajoli, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Hospital do Câncer A.C. Camargo, São Paulo, Brazil

,Accepted 15 February 2001.

References 

  1. Nag S, Orton C, Young D, et al.  The American Brachytherapy Society survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol. 1999;73:111–118
  2. Brasil. Ministério da Saúde. Secretaria Nacional de Assistência à Saúde. Instituto Nacional de Câncer. Estimativa da incidência e mortalidade por câncer no Brasil 2000. Rio de Janeiro, 2000.
  3. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer (Is there an optimal fractionation schedule?). Int J Radiat Oncol Biol Phys. 1999;43:359–366
  4. Bastin KT, Buchler DA, Stitt JA, et al.  Resource utilization (High dose rate versus low dose rate brachytherapy for gynecologic cancer). Am J Clin Oncol. 1993;16:256–263
  5. Wright J, Jones G, Whelan T, et al.  Patient preference for high- or low-dose-rate brachytherapy in carcinoma of the cervix. Radiother Oncol. 1994;33:187–194
  6. International Federation of Gynecology, and Obstetrics . Staging of gynecologic cancer; cervical and vulva. Int J Gynecol Cancer. 1995;5:319
  7. Fowler JF. Brief summary of radiobiological principles in fractionated radiotherapy. Semin Radiat Oncol. 1992;2:16–21
  8. ICRU Report 38. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: International Commission on Radiation Units and Measurements; 1985. p. 1–20.
  9. Kaplan E, Meier P. Non-parametric estimations from complete observations. J Am Stat Assoc. 1953;53:457–480
  10. Cox DR. Regression models and life table. (with discussion) J R Stat Soc. 1972;13:187–220
  11. Cox JF, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  12. Eifel PJ. High-dose-rate brachytherapy for carcinoma of the cervix (High tech or high risk?). Int J Radiat Oncol Biol Phys. 1992;24:383–386
  13. Nag S, Erickson B, Thomadsen B, et al.  The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–221
  14. Coia L, Won M, Lanciano R, et al.  The patterns of care outcome study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer. 1990;9:431–436
  15. Perez CA, Marvin Camel H, Kuske RR, et al.  Radiation therapy alone in the treatment of carcinoma of the uterine cervix (A 20-year experience). Gynecol Oncol. 1986;23:127–140
  16. Montana GS, Fowler WC, Varia MA, et al.  Carcinoma of the cervix, stage III (Results of radiation therapy). Cancer. 1986;57:148–154
  17. Hanks GE, Herring DF, Kramer S, et al.  Patterns of care outcome studies (Results of the national practice in cancer of the cervix). Cancer. 1983;51:956–967
  18. Barillot I, Horiot JC, Pigneaux J, et al.  Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French Cooperative Study (Update and multivariate analysis of prognostic factors). Int J Radiat Oncol Biol Phys. 1997;38:969–978
  19. Federation International for Gynecologic, and Obstetrics . Annual report on the results of treatment in gynaecological cancer. J Epidemiol Biostat. 1998;3:1–168
  20. Petereit DG. High dose rate brachytherapy for carcinoma of the cervix. 41st Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Refresher course No 404. San Antonio, TX; 1999.
  21. Lorvidhaya V, Tonusin A, Changwiwit W, et al.  High-dose-rate afterloading brachytherapy in carcinoma of the cervix. An experience of 1992 patients. Int J Radiat Oncol Biol Phys. 2000;46:1185–1191
  22. Perez CA, Breaux S, Madoc-Jones H, et al.  Radiation therapy alone in the treatment of carcinoma of the uterine cervix. Analysis of tumor recurrence. Cancer. 1983;51:1393–1402
  23. Garipagaoglu M, Yalvac S, Kose MF, et al.  Treatment results and prognostic factors in inoperable carcinoma of the cervix treated with external plus high dose brachytherpy. Cancer Lett. 1999;136:17–26
  24. Busch M, Meden H, Meibodi F, et al.  Long term results of definitive radiotherapy for cervical carcinoma using four applications of high dose rate afterloading. Cancer. 1999;86:1520–1527
  25. Jones B, Pryce PL, Blake PR, et al.  High dose rate brachytherapy practice for the treatment of gynaecological cancers in the UK. Br J Radiol. 1999;72:371–377
  26. Stitt JA. High dose rate brachytherapy in the treatment of cervical carcinoma. Hematol Oncol Clin North Am. 1999;13:585–593
  27. Kapp KS, Stuecklschweiger GF, Kapp DS, et al.  Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;42:531–540
  28. Orton CG. High and low dose-rate brachytherapy for cervical carcinoma. Acta Oncol. 1998;37:117–125
  29. Takeshi K, Katsuyuki K, Yoshiaki T, et al.  Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix (Retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters). Int J Radiat Oncol Biol Phys. 1998;41:319–327
  30. Wang CJ, Leung SW, Chen HC, et al.  High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma. 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme. Int J Radiat Oncol Biol Phys. 1997;38:391–398
  31. Fyles A, Keane TJ, Barton M, et al.  The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 1992;25:273–279
  32. Lanciano RM, Pajak TF, Martz K, et al.  The influence of treatment time on outcome for squamous cell cancer of the uterine cervix. Cancer. 1992;69:2124–2130
  33. Perez CA, Grigsby PW, Castro-Vita H, et al.  Carcinoma of the uterine cervix (Impact of prolongation of treatment time and timing of brachytherapy on outcome of radiation therapy). Int J Radiat Oncol Biol Phys. 1995;32:1275–1288
  34. Delaloye JF, Couke PA, Pampallona S, et al.  Effect of total treatment time on event-free survival in carcinoma of the cervix. Gynecol Oncol. 1996;60:42–48
  35. Han I, Orton C, Shamsa F, et al.  Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer (Experience over ten years). Radiat Oncol Invest. 1999;7:289–296
  36. Girinsky T, Rey A, Roche B, et al.  Overall treatment time in advanced cervical carcinomas. A critical parameters in treatment outcome. Int J Radiat Oncol Biol Phys. 1993;27:1051–1056
  37. Chatani M, Matayoshi Y, Masaki N, et al.  High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation. Strahlenther Onkol. 1997;173:379–384
  38. Petereit DG, Sarkaria JN, Potter DM, et al.  High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer. Analysis of tumor recurrence. The University of Wisconsin experience. Int J Radiat Oncol Biol Phys. 1999;45:1267–1274
  39. Berkowits RS, Ehrmann RL, Lavizzo-Moures R, et al.  Invasive cervical carcinoma in young women. Gynecol Oncol. 1979;8:31–316
  40. Prempree T, Patanaphan V, Sewchand W, et al.  The influence of patient age and tumor grade on the prognosis of carcinoma of the cervix. Cancer. 1983;51:1764–1774
  41. Dattoli MJ, Gretz HF, Beller U, et al.  Analysis of multiple prognostic factors in patients with stage IB cervical cancer (Age as a major determinant). Int J Radiat Oncol Biol Phys. 1989;17:41–47
  42. Meanwell CA, Kely KA, Wilson S, et al.  Young age as a prognostic factor in cervical cancer. Analysis of population based on data from 10,022 cases. Br J Med. 1998;296:386–391
  43. Van der Graaf Y, Peer PGM, Zielhuis GA, et al.  Cervical cancer survival in Nijmegan region, The Netherlands 1970 to 1985. Gynecol Oncol. 1988;30:51–56
  44. Rutledge FN, Mitchel MF, Nunsell S, et al.  Youth as a prognostic factors in carcinoma of the uterine cervix (A matched analysis). Gynecol Oncol. 1992;44:123–130
  45. Selke P, Roman TN, Souhami L, et al.  Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1993;27:803–809
  46. Kapp KS, Stuecklschweiger GF, Kapp DS, et al.  Carcinoma of the cervix (Analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy). Radiother Oncol. 1997;42:1433–1453
  47. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993;118:201–210
  48. Lanciano RM, Won M, Coia L, et al.  Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix (A final report of the 1973 and 1978 Patterns of Care Studies). Int J Radiat Oncol Biol Phys. 1991;20:667–676
  49. Clark BG, Souhami L, Roman TN, et al.  The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1997;38:989–993
  50. Ongino I, Kitamura T, Okamoto N, et al.  Late rectal complications following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys. 1995;31:725–734
  51. Chen SW, Liang JA, Yang SN, et al.  The prediction of late rectal complictions and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer (In vivo dosimetric analysis). Radiat Med. 1999;17:289–293
  52. Morris M, Eifel PJ, Wharton JT, et al.  Complications of therapy for cervical cancer. Cancer Bull. 1990;42:83–88
  53. Van Nagell JR, Parker JC, Maruyama Y, et al.  Bladder or rectal injury following radiotherapy for cervical cancer. Am J Obstet Gynecol. 1974;119:727–732
  54. Levenback C, Eifel PJ, Burke TW, et al.  Hemorrhagic cystitis following radiotherapy for stage IB cancer of the cervix. Gynecol Oncol. 1994;55:206–210
  55. Nag S, Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:507–513
  56. Schoeppel SL, Frass BA, Hopkins MP, et al.  A CT-compatible version of the Fletcher system intracavitary applicator (Clinical application and 3-dimensional treatment planning). Int J Radiat Oncol Biol Phys. 1989;17:1103–1109
  57. Uno T, Itami J, Aruga M, et al.  High dose rate brachytherapy for carcinoma of the cervix (Risk factors for late rectal complications). Int J Radiat Oncol Biol Phys. 1998;40:615–621
  58. Kapp KS, Stuecklschweiger GF, Kapp DS, et al.  Dosimetry for intracavitary placements for uterine and cervical carcinoma (Results of orthogonal film, TLD, and CT assisted techniques). Radiother Oncol. 1992;24:137–146
  59. Stuecklschweiger GF, Arian-Schad KS, Poier E, et al.  Bladder and rectal dose of gynecologic high-dose rate implants (Comparison of orthogonal radiographic measurements with in vivo and CT-assisted measurements). Radiology. 1991;181:889–894
  60. Lanciano RM, Martz K, Montana GS, et al.  Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. Cancer. 1992;69:2124–2130
  61. Perez CA, Fox S, Lockett MA. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix (Analysis of two different methods). Int J Radiat Oncol Biol Phys. 1991;21:885–894
  62. Komaki R, Pajak TF, Marcial VA, et al.  Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the Radiation Therapy Oncology Group 88–05. Cancer. 1994;73:2619–2634
  63. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix (An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy). Int J Radiat Oncol Biol Phys. 1999;433:763–775
  64. Strockbine MF, Hancock JE, Fletcher GH. Complications in 831 patients with squamous cell carcinoma of the intact uterine cervix treated with 3000 rads or more whole pelvis irradiation. Am J Roentgenol Radium Ther Nucl Med. 1970;108:293–304
  65. Hamberger AD, Unal A, Gershenson DM. Analysis of the servere complications of irradiation of carcinoma of the cervix (Whole pelvis irradiation and intracavitary radium). Int J Radiat Oncol Biol Phys. 1983;9:367–371
  66. Quilty PM. A report of late rectosigmoid morbidity in patients with advanced cancer of the cervix, treated with a 6-week pelvic brick technique. Clin Radiol. 1988;39:297–300
  67. Unal A, Hamberger AD, Seski JC, et al.  An analysis of the severe complications of irradiation of carcinoma of the uterine cervix (Treatment with intracavitary radium and parametrial irradiation). Int J Radiat Oncol Biol Phys. 1981;7:999–1004
  68. Perez CA, Grigsby PW, Lockett MA, et al.  Radiation therapy morbidity in carcinoma of the uterine cervix (Dosimetric and clinical correlation). Int J Radiat Oncol Biol Phys. 1999;44:855–866

PII: S0360-3016(01)01533-4

International Journal of Radiation Oncology * Biology * Physics
Volume 50, Issue 5 , Pages 1123-1135 , 1 August 2001

Article Tools

* Image Usage & Resolution